(KUTV) In 2014, medical marijuana producers took in about $40 million from sales, according to a report from cannabis business research firm Cannabist. But because of a shortage of labs to test those products, just 21 percent of the high-end products registered in California qualified for any type of regulatory approval.

Leave a Reply

Your email address will not be published. Required fields are marked *